États-Unis · Plateformes & données · MarketBeat

PTC Therapeutics (NASDAQ:PTCT) to Buy Back $500 million in Outstanding Stock

Publié par MarketBeat · États-Unis il y a 1 h

PTC Therapeutics (NASDAQ:PTCT - Get Free Report) announced that its Board of Directors has approved a stock buyback program on Tuesday, November 3rd, RTT News reports. The company…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

PTC Therapeutics (NASDAQ:PTCT) to Buy Back $500 million in Outstanding Stock

À lire aussi

Arista forecasts $18.5B FY 2027 revenue amid 38%-40% growth outlook and $7B AI fabrics target

ADT: 3 Key Takeaways for Long-Term Investors

Market analysts react to US midterm election results

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Texas governor race tightens in prediction markets, but Abbott remains favored

Market News

PTC Therapeutics (NASDAQ:PTCT) to Buy Back $500 million in Outstanding Stock

Partager

À lire aussi

Arista forecasts $18.5B FY 2027 revenue amid 38%-40% growth outlook and $7B AI fabrics target

ADT: 3 Key Takeaways for Long-Term Investors

Market analysts react to US midterm election results

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Texas governor race tightens in prediction markets, but Abbott remains favored

Market News